Law360, New York (August 28, 2009) -- A federal judge has cleared the way for the multidistrict litigation alleging Pfizer Inc. and its Warner-Lambert Co. subsidiary engaged in a scheme to use patent litigation to delay generic competition for the epilepsy drug Neurontin to move forward.
Judge Faith S. Hochberg of the U.S. District Court for the District of New Jersey on Thursday shot down the pharmaceutical giant’s bid to dismiss the case, allowing all of...
